Medical Writing Market Size, Share, By Type of Writing (Clinical Writing, Regulatory Writing, Scientific Writing, and Medical Communications), By Application (Medical Journalism, Medical Education, Medico-Marketing, and Others), By Delivery Model (In-house Medical Writing, Outsourcing, and Hybrid Model), By End-User (Contract Research Organizations, Pharma and Biotechnological Companies, and Other End Users Source), and By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI556824 | Publish Date: August 2024 | No. of Pages: 184

Medical Writing Market Companies

  • Parexel International Corporation
  • Trilogy Writing & Consulting GmBH
  • Freyr
  • Cactus Communications
  • Labcorp Drug Development
  • IQVIA Holdings Inc.
  • Omics International
  • Synchrogenix
  • Siro Clinpharm Private Limited
  • Quanticate
  • Inclin, Inc.

Recent News:

  • Cognizant and Yseop, a well-known artificial intelligence (AI) software company, partnered in July 2024 to speed up and increase the supply of scientific information in the biopharma industry through generative AI. The firms hope to raise development productivity and accelerate the market release of breakthrough, life-saving pharmaceuticals by utilizing Yseop Copilot to improve medical writing in the life sciences. Cognizant intends to help Yseop gain value and acceptance in the life sciences business while aiding AI's profound digital transformation.
  • Certara, Inc., well-known for its model-informed drug development services, will launch its new CoAuthor regulatory authoring product in June 2024. This cutting-edge application is designed to assist medical writers by merging generative AI, document templates, and Microsoft. CoAuthor aims to accelerate the creation of regulatory documents while retaining a "human in the loop" to oversee the generative AI's contributions. According to Certara CEO William Feehery, Ph.D., the program is tailored to the drug research sector, providing a secure and specialized AI solution.